TCGA analysis confirmed that lower HER2 mRNA expression was associated with increased chemokine gene expression.<h4>Discussion</h4>In HR+/HER2- breast cancer, tumors with lower HER2 mRNA expression exhibit higher lymphocytic infiltration, suggesting the presence of a distinct immunologically active subset. The gene discussed is ERBB2; the disease is breast cancer.